MiR-338-5p Promotes Inflammatory Response of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Targeting SPRY1

Journal of Cellular Biochemistry

Volumn 118, Issue 8, 2017, Pages 2295-2301

  Yang, Yan ^a   Wang, Yanfeng ^a   Liang, Qingwei ^a   Yao, Lutian ^a   Gu, Shizhong ^a   Bai, Xizhuang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

FIBROBLAST LIKE SYNOVIAL CELLS (SFs); MIR 338 5p; RHEUMATOID ARTHRITIS; SPRY1

Indexed keywords

CORTICOSTERONE; CYCLOOXYGENASE 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 338 5P; PEPTIDES AND PROTEINS; SPRY 1 PROTEIN; UNCLASSIFIED DRUG; COLLAGEN; MIRN338 MICRORNA, HUMAN; PTGS2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MOUSE MODEL; MTT ASSAY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; CYCLOOXYGENASE 2; FIBROBLASTS; HUMANS; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; MALE; MICE; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; SYNOVIOCYTES;

EID: 85014243676     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25883     Document Type: Article

References (31)

1. Besse A, Sana J, Lakomy R, Kren L, Fadrus P, Smrcka M, Slaby O. 2016. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumour Biol 37(6):7719–7727.
2. Bigot A, Duddy WJ, Ouandaogo ZG, Negroni E, Mariot V, Ghimbovschi S, Harmon B, Wielqosik A, Loiseau C, Devaney J, Dumonceaux J, Butler-Browne G, Mouly V, Duguez S. 2015. Age-associated methylation suppresses SPRY1, leading to a failure of Re-quiescence and loss of the reserve stem cell pool in elderly muscle. Cell Rep 13(6):1172–1182.
3. Chen X, Wei L, Zhao S. 2016. MiR-338 inhibits the metastasis of lung cancer by targeting integrin beta3. Oncol Rep 36(3):1467–1474.
4. Darimipourain M, Wang S, Ittmann M, Kwabi-Addo B. 2011. Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer. Prostate Cancer Prostatic Dis 14(4):279–285.
5. Edwin F, Anderson K, Ying C, Patel TB. 2009. Intermolecular interactions of Sprouty proteins and their implications in development and disease. Mol Pharmacol 76(4):679–691.
6. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. 1998. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92(2):253–263.
7. Kim HJ, Bar-Sagi D. 2004. Modulation of signalling by Sprouty: A developing story. Nat Rev Mol Cell Biol 5(6):441–450.
8. Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. 2004. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64(14):4728–4735.
9. Li YT, Chen SY, Wang CR, Liu MF, Lin CC, Jou IM, Shiau AL, Wu CL. 2012. Brief report: Amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223. Arthritis Rheum 64(10):3240–3245.
10. Lu MC, Yu CL, Chen HC, Yu HC, Huang HB, Lai NS. 2014. Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production. Clin Exp Immunol 177(3):641–651.
11. Ma X, He X, Dong P, Xue D, Song D, Xu H, Zhang X. 2016. [miR-338-5p modulates B cell biological functions by targeting NF-kappaB1]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32(11):1475–1480.
12. Mason JM, Morrison DJ, Basson MA, Licht JD. 2006. Sprouty proteins: Multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol 16(1):45–54.
13. Mohammad AA, Rahbar A, Lui WO, Davoudi B, Catrina A, Stragliotto G, Mellbin L, Hamsten A, Rydén L, Yaiw KC, Soderberg-Naucler C. 2014. Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls. PLoS ONE 9(12):e113740.
14. Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. 2011. Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmun Rev 11(2):123–131.
15. Ruedel A, Dietrich P, Schubert T, Hofmeister S, Hellerbrand C, Bosserhoff AK. 2015. Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. Int J Clin Exp Pathol 8(5):4953–4962.
16. Schellekens GA, Visser H, De Jong BAW, Van Den Hoogen FFHJ, Hazes JMW, Breedveld FC, Van Venrooij WJ. 2000. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis & Rheumatism 43(1):155–163.
17. Sharma B, Joshi S, Sassano A, Majchrzak B, Kaur S, Aggarwal P, Nabet B, Bulic M, Stein BL, McMahon B, Baker DP, Fukunaga R, Altman JK, Licht JD, Fish EN, Platanias LC. 2012. Sprouty proteins are negative regulators of interferon (IFN) signaling and IFN-inducible biological responses. J Biol Chem 287(50):42352–42360.
18. Smigielska-Czepiel K, van den Berg FA, Jellema P, van der Lei FRJ, Bijzet J, Kluiver J, Boots AM, Brouwer E, Kroesen BJ. 2014. Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun 15(2):115–125.
19. Song YJ, Li G, He JH, Guo Y, Yang L. 2015. Bioinformatics-Based identification of microRNA-Regulated and rheumatoid arthritis-Associated genes. PLoS ONE 10(9):e0137551.
20. Stanczyk J, Ospelt C, Karouzakis E, Filer A, Raza K, Kolling C, Gay R, Buckley CD, Tak PP, Gay S, Kyburz D. 2011. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 63(2):373–381.
21. Sun J, Yan P, Chen Y, Chen Y, Yang J, Xu G, Mao H, Qiu Y. 2015. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3beta/beta-catenin pathway. Diagn Pathol 10:72.
22. Tadolini M, Garcia-Prats AJ, D'Ambrosio L, Hewison C, Centis R, Schaaf HS, Marais BJ, Ferreira H, Caminero JA, Jonckheere S, Sinha A, Herboczek K, Khaidarkhanova Z, Hayrapetyan A, Khachatryan N, Urtkmelidze Ia, Loreti C, Esposito S, Matteelli A, Furin J, Varaine F, Migliori GB. 2016. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: Early experiences and challenges. Eur Respir J 48(3):938–943.
23. Terada N, Shiraishi T, Zeng Y, Aw-Yong KM, Mooney SM, Liu Z, Takahashi S, Luo J, Lupold SE, Kulkarni P, Getzenberg RH. 2014. Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation. J Cell Biochem 115(9):1505–1515.
24. Trenkmann M, Brock M, Gay RE, Michel BA, Gay S, Huber LC. 2013. Tumor necrosis factor alpha-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-kappaB signaling. Arthritis Rheum 65(4):916–927.
25. van der Geest FKS, Smigielska-Czepiel K, Park JA, Abdulahad WH, Kim HW, Kroesen BJ, den Berg A, Boots AM, Lee EB, Brouwer E. 2015. SF Treg cells transcribing high levels of Bcl-2 and microRNA-21 demonstrate limited apoptosis in RA. Rheumatology (Oxford) 54(5):950–958.
26. Xing Z, Yu L, Li X, Su X. 2016. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p. Cell Biosci 6:53.
27. Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL, Li BX, Shen YW, Tao LY, Zhao ZQ. 2014. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep 10(1):161–168.
28. Yang S, Yang Y. 2015. Downregulation of microRNA221 decreases migration and invasion in fibroblastlike synoviocytes in rheumatoid arthritis. Mol Med Rep 12(2):2395–2401.
29. Yang X, Gong Y, Tang Y, Li H, He Q, Gower L, Liaw L, Friesel RE. 2013. Spry1 and Spry4 differentially regulate human aortic smooth muscle cell phenotype via Akt/FoxO/myocardin signaling. PLoS ONE 8(3):e58746.
30. Zanotti S, Gibertini S, Curcio M, Savadori P, Pasanisi B, Morandi L, Cornelio F, Mantegazza R, Mora M. 2015. Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta 1852(7):1451–1464.
31. Zhuang Y, Dai J, Wang Y, Zhang H, Li X, Wang C, Cao M, Liu Y, Cai H, Zhang D, Wang Y. 2016. MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting L PA1. Am J Transl Res 8(7):3197–3205.